デフォルト表紙
市場調査レポート
商品コード
1475015

合成脂質の世界市場の評価:形状別、用途別、地域別、機会、予測(2017年~2031年)

Synthetic Lipids Market Assessment, By Form [Solid, Liquid], By Application [Personal Care and Cosmetics, Pharmaceuticals, Food], By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 229 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
合成脂質の世界市場の評価:形状別、用途別、地域別、機会、予測(2017年~2031年)
出版日: 2024年05月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 229 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の合成脂質の市場規模は、2023年の25億6,000万米ドルから2031年に39億3,000万米ドルに達すると予測され、2024年~2031年の予測期間にCAGRで5.5%の成長が見込まれます。市場の拡大は、パーソナルケア製品や化粧品における合成脂質の利用の増加と、製薬部門の急速な拡大によって支えられています。

製薬部門による合成脂質への需要の増加は、世界の合成脂質の市場規模を拡大する主な要因の1つです。製薬部門による合成脂質の需要の伸びは、合成脂質が単一の脂質から構成され、その品質が知られていることから、天然脂質と比較してさまざまな利点があることによるものと考えられます。また、組織由来の脂質は通常、ウシ由来または卵由来の脂質の組み合わせです。合成脂質は組織由来の脂質とは異なり、タンパク質やウィルスの混入のリスクはなく、バッチ間のばらつきもありません。さらに、精製技術や製造工程を最適化し、品質の優れた出発物質を選択することで、合成脂質の純度を高めることができます。そのため、製薬産業からの需要が高まり、市場の拡大を支えています。

さまざまな政府と市場の主要企業との提携が、さらに市場に有利な成長機会をもたらしています。例えば、2022年6月、特殊化学品の主要企業の1つであるEvonikは、mRNAベースの治療薬を生産する脂質生産施設を建設するため、米国政府とのパートナーシップで2億2,000万米ドルの投資を行うことを発表しました。インディアナ州ラファイエットにあるチペカヌーの施設は、柔軟な脂質生産を可能にすると期待されています。このプロジェクトは2023年初頭に建設が開始され、2025年に稼動を開始する予定です。

化粧品・パーソナルケア産業の拡大が市場需要を押し上げる

世界中のさまざまな地域で、個人による化粧品やパーソナルケア製品への投資が増加しており、市場に有利な成長機会をもたらしています。例えば、Forbesが2023年に発表した記事によると、米国の化粧品の市場規模は2022年に約500億米ドルでした。この成長が合成脂質の需要を強化し、予測期間の市場拡大を後押しする見込みです。この市場拡大は、健康な皮膚バリアの形成に不可欠なコレステロールの性質に起因していると考えられます。これらは効果的に機能させるため、バリア修復保湿剤に添加されることが多いです。皮膚バリアの定期的な修復は、経皮的な水分の損失を防ぎ、アレルゲン、刺激物、バクテリアを皮膚から遠ざけるために不可欠です。動物虐待に対する意識の高まりと動物福祉に対する懸念の高まりにより、世界中の人々がヴィーガン製品に切り替えつつあります。このような懸念は、パーソナルケア製品や化粧品への要求を促進し、植物が合成コレステロールを生成しないため、合成コレステロールの需要を押し上げ、市場の拡大を支えています。さまざまな化粧品メーカーやパーソナルケアメーカーが、顧客にヴィーガン向けのバリア修復保湿剤を提供するために合成コレステロールの採用を増やしていることが、市場需要を増大させています。

食品産業からの製品要求の増加が市場需要を押し上げる

市販のヒト乳脂肪代替物(HMFS)への要求の高まりが、市場の成長にプラスの影響を与えています。ヒト乳脂肪は乳児の一日の摂取カロリーの約50%を占める主要エネルギー源です。また、脂溶性ビタミンと重要な脂肪酸の不可欠な供給源でもあります。パルミチン酸とオレイン酸がヒト乳脂肪に含まれる主な脂肪酸で、それぞれ25%と40%を占めます。

しかし、加水分解された遊離脂肪酸であるパルミチン酸は、新生児の成長に必要なミネラルやカルシウムと不溶性の塩を形成し、便中に排泄されて便秘を引き起こし、カルシウムの吸収を妨げます。従って、HMFSを配合する際は、パルミチン酸の組成と量を調整することが不可欠です。市販のHMFSは、ヒトの乳脂肪に匹敵する配分を持ち、脂肪酸を含む合成脂質です。そのため、乳児用調製粉乳の合成に欠かせない原材料となっています。例えば、米国国際貿易委員会の推計によると、世界の乳児用調製粉乳の輸出額は96億米ドル、輸出量は100万トンでした(ともにEU域内貿易を除く)。したがって、乳児用調製粉乳の需要の増加が合成脂質の需要を押し上げ、市場成長を後押ししています。

当レポートでは、世界の合成脂質市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

  • 市場の認知度と製品情報
  • ブランド認知度とロイヤルティ
  • 購入決定において考慮される要素
  • 購入頻度
  • 購入媒体

第5章 世界の合成脂質市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • 形状別
    • 固体
    • 液体
  • 用途別
    • パーソナルケア・化粧品
    • 医薬品
    • 食品
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2023年)

第6章 世界の合成脂質市場の見通し:地域別(2017年~2031年)

  • 北米
    • 市場規模と予測
    • 形状別
    • 用途別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 サプライサイド分析

  • 生産能力:企業別
  • 生産:企業別
  • 運転効率:企業別
  • 主なプラントの所在地(最大25ヶ所)

第8章 市場マッピング(2023年)

  • 形状別
  • 用途別
  • 地域別

第9章 マクロ環境と産業構造

  • 需給分析
  • 輸入輸出分析
  • サプライチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第10章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第11章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場企業5社)
  • 特許分析(該当する場合)

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • CordenPharma
  • Sigma-Aldrich (Merck Group)
  • Merck Millipore
  • Avanti Polar Lipids, Inc
  • Lipoid GmbH
  • NOF EUROPE GmbH
  • Croda Pharma
  • NucleoSyn
  • Evonik Industries AG
  • ABITEC Corporation

第15章 戦略的推奨

第16章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 3.Global Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 4.Global Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 5.Global Synthetic Lipids Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 8.North America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 9.North America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 10.North America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 13.United States Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 14.United States Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 15.Canada Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 17.Canada Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 18.Canada Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 19.Mexico Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 21.Mexico Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 22.Mexico Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 23.Europe Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 25.Europe Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 26.Europe Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 27.Europe Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 30.Germany Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 31.Germany Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 32.France Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 34.France Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 35.France Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 36.Italy Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 38.Italy Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 39.Italy Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 40.United Kingdom Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 42.United Kingdom Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 43.United Kingdom Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 44.Russia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 46.Russia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 47.Russia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 48.Netherlands Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 50.Netherlands Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 51.Netherlands Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 52.Spain Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 54.Spain Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 55.Spain Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 56.Turkey Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 58.Turkey Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 59.Turkey Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 60.Poland Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 62.Poland Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 63.Poland Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 64.South America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 66.South America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 67.South America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 68.South America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 71.Brazil Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 72.Brazil Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 73.Argentina Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 75.Argentina Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 76.Argentina Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 77.Asia-Pacific Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 79.Asia-Pacific Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 80.Asia-Pacific Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 81.Asia-Pacific Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 82.India Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 84.India Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 85.India Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 86.China Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 88.China Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 89.China Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 90.Japan Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 92.Japan Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 93.Japan Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 94.Australia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 96.Australia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 97.Australia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 98.Vietnam Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 100.Vietnam Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 101.Vietnam Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 102.South Korea Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 104.South Korea Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 105.South Korea Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 106.Indonesia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 108.Indonesia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 109.Indonesia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 110.Philippines Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 112.Philippines Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 113.Philippines Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 114.Middle East & Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 116.Middle East & Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 117.Middle East & Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 118.Middle East & Africa Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 121.Saudi Arabia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 122.Saudi Arabia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 123.UAE Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 125.UAE Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 126.UAE Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 127.South Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 129.South Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 130.South Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 131.By Form Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11282

Global synthetic lipids market is projected to witness a CAGR of 5.5% during the forecast period 2024-2031, growing from USD 2.56 billion in 2023 to USD 3.93 billion in 2031F. The market expansion is supported by the increasing utilization of synthetic lipids in personal care and cosmetic products and rapid expansion of pharmaceutical sector.

The increasing demand for synthetic lipids by the pharmaceutical sector is one of the major factors augmenting the global synthetic lipids market size. The rising requirement of synthetic lipids by the pharmaceutical sector can be attributed to the various advantages offered by the synthetic lipids over their natural counterparts as they consist of a single lipid, the quality of which is known. Also, tissue-derived lipids are usually a combination of bovine-derived or egg-derived lipids. Synthetic lipids, unlike tissue-derived lipids, do not possess a risk of protein or viral contamination or show batch-to-batch variability. Additionally, the purity of synthetic lipids can be enhanced by optimizing the purification techniques and manufacturing processes and by selecting starting materials with superior quality. Thus, boosting their demand from the pharmaceutical sector and supporting the market expansion.

Collaborations between different governments and leading players of the market are further providing lucrative growth opportunities to the market. For instance, in June 2022, Evonik, one of the leading specialty chemicals companies announced an investment of USD 220 million in partnership with the government of the United States to build lipid production facility for producing mRNA-based therapies. The Tippecanoe site in Lafayette, Indiana is expected to ensure flexible lipid production. The construction for the project commenced in early 2023 and is expected to go onstream in 2025.

Expansion of the Cosmetics and Personal Care Industry Boosts Market Demand

The increasing investments by individuals in various regions across the globe in cosmetics and personal care products is providing lucrative growth opportunities to the market. For instance, according to an article published by Forbes in 2023, the value of the cosmetics market in the United States was approximately USD 50 billion in 2022. The growth will bolster the demand for synthetic lipids and aid the expansion of the market over the forecast period. The expansion can be attributed to the essential nature of cholesterol in making a healthy skin barrier. They are often added to barrier repair moisturizers to function effectively. Regular repair of the skin barrier is essential for preventing trans-dermal water loss and for keeping allergens, irritants, and bacteria away from the skin. Due to the growing awareness about animal cruelty and rising concerns about animal welfare, individuals across the globe are switching to vegan products due to increasing consciousness. Such concerns propel the requirement for personal care products and cosmetics and support the market expansion as they boost the demand for synthetic cholesterol as plants do not produce it. The increasing adoption of synthetic cholesterol by various cosmetic and personal care manufacturers to provide vegan barrier repair moisturizers to their customers is augmenting the market demand.

Increasing Product Requirement from Food Industry Boosts Global Synthetic Lipids Market Demand

The rising requirement for commercial human milk fat substitutes (HMFSs) is positively influencing the growth of the market. Human milk fat provides approximately 50% of babies' daily calorie intake and is their primary energy source. It is also an essential source of fat-soluble vitamins and vital fatty acids. Palmitic acid and oleic acid are the main fatty acids available in human milk fat, constituting up to 25% and 40%, respectively.

However, palmitic acid, a hydrolyzed free fatty acid forms an insoluble salt with the minerals and calcium that are required by the newborns for growth is excreted in feces, causing constipation, and preventing the absorption of calcium. Hence, it is essential to regulate the composition and amount of palmitic acid while formulating HMFSs. Commercial HMFSs are synthetic lipids that have a distribution comparable to that of human milk fat and contain fatty acids. Thus, making it an essential raw material in synthesis of infant food products (formula). For instance, according to the U.S. International Trade Commission estimates, the global infant and child formula exports were valued at USD 9.6 billion with a volume of 1 million mt (these figures exclude the intra-EU trade). Therefore, the increase in the requirement for infant formula is boosting the demand for synthetic lipids and aiding the market growth.

North America to Hold Significant Share in the Market

The strong presence of leading market players and rapid expansion of pharmaceutical and food sectors in the region are boosting the growth of North America synthetic lipids market. According to the U.S. Department of Agriculture, food, agriculture, and related industries contributed approximately USD 1.420 trillion to the GDP of the United States in 2022. Additionally, estimates suggest that the United States pharmaceutical industry generated USD 550 billion in 2021 in revenue. Due to the growth and expansion in food and pharmaceutical sectors in the region, the requirement for synthetic lipids is increasing as they find various applications in the sector. Owing to the success of mRNA vaccines, Moderna, a United States based biotechnology company is now working on the development of vaccines for a host of diseases including Zika, Malaria, tuberculosis, and HIV. Hence, the increase of research and development activities amongst leading pharmaceutical and biotechnological companies in the region will further boost the requirement for synthetic lipids, thus propelling the growth of the market.

Solid Synthetic Lipids Account for Significant Global Synthetic Lipids Market Share

The growth of the segment is supported by the increasing research activities conducted by various leading research institutions across the globe on solid lipid nanoparticles. For instance, these institutes include, the Department of Chemistry, Indian Institute of Technology Kharagpur. The researchers evaluated the stability and physicochemical characterizations and in vitro evaluations of CUR-loaded solid nanoparticles that were prepared with the help of biocompatible synthetic lipids. The solid lipid nanoparticles are showing promising results as drug delivery vehicles for ensuring the delivery of different drug types, especially poorly water-soluble drugs. The solid lipid nanoparticles can play an essential role in ensuring the delivery of curcumin in the disease sites with enhanced overall effects and improved bioavailability.

Rising Requirements from the Pharmaceutical Sector Aids Global Synthetic Lipids Market Growth

The increasing utilization of synthetic lipids for development of RNA therapies is boosting the growth of the market. MRNA-based systems are deployed for development of vaccines where viral proteins are identified as the potential candidates for vaccines. These systems are preferred as they are less prone to anti-vector immunity and genome integration. For instance, the recent success of BioNTech and Moderna has now resulted in the increase of clinical and preclinical studies of mRNA to other therapeutic and infectious disease applications, thus boosting the growth of the market. Moreover, the consistency and quality of lipids utilized in different pharmaceutical formulations is extremely essential. Lipid quality, type, and source are carefully considered prior to the initiation of the process as they directly impact the properties and impurity profile of the final drug. Furthermore, the choice of lipid impacts the particle characteristics, including release properties, structure, and stability. It is essential to control various impurities such as trans fatty acids in lipids as they can alter the RNA release and particle stability. Thus, synthetic lipids offer various advantages as opposed to natural lipids because the former is derived from a single lipid with known quality, and the chances of batch-to-batch variability are decreased. It, in turn, augments the demand for synthetic lipids and supports the growth of the market.

Key Players Landscape and Outlook

Global synthetic lipids market expansion is supported by increasing investments by leading market players towards the development of new lipid manufacturing plants. For instance, in March 2023, Evonik announced the opening of a new lipid manufacturing facility in Hanau, Germany. According to the company's chemical specialist the lipids produced will be used for gene therapies and RNA drugs aimed at cancer and infectious diseases, among others. The facility supports the production of proprietary as well as custom lipids. Such investments are expected to bolster synthetic

lipids' production, supporting the market's expansion.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Synthetic Lipids Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Form
    • 5.2.1.Solid
    • 5.2.2.Liquid
  • 5.3.By Application
    • 5.3.1.Personal Care and Cosmetics
    • 5.3.2.Pharmaceuticals
    • 5.3.3.Food
  • 5.4.By Region
    • 5.4.1.North America
    • 5.4.2.South America
    • 5.4.3.Europe
    • 5.4.4.Asia-Pacific
    • 5.4.5.Middle East & Africa
  • 5.5.By Company Market Share (%), 2023

6.Global Synthetic Lipids Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Form
      • 6.1.2.1.Solid
      • 6.1.2.2.Liquid
    • 6.1.3.By Application
      • 6.1.3.1.Personal Care and Cosmetics
      • 6.1.3.2.Pharmaceuticals
      • 6.1.3.3.Food
    • 6.1.4.United States*
      • 6.1.4.1.Market Size & Forecast
        • 6.1.4.1.1.By Value
        • 6.1.4.1.2.By Volume
      • 6.1.4.2.By Form
        • 6.1.4.2.1.Solid
        • 6.1.4.2.2.Liquid
      • 6.1.4.3.By Application
        • 6.1.4.3.1.Personal Care and Cosmetics
        • 6.1.4.3.2.Pharmaceuticals
        • 6.1.4.3.3.Food
    • 6.1.5.Canada
    • 6.1.6.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Form
  • 8.2.By Application
  • 8.3.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.CordenPharma
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Sigma-Aldrich (Merck Group)
  • 14.3.Merck Millipore
  • 14.4.Avanti Polar Lipids, Inc
  • 14.5.Lipoid GmbH
  • 14.6.NOF EUROPE GmbH
  • 14.7.Croda Pharma
  • 14.8.NucleoSyn
  • 14.9.Evonik Industries AG
  • 14.10.ABITEC Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer